Priority Date: 04.12.08 (US 20080119844P)

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

  • Application ID: EP16175661
  • Status: EXAMINATION REQUESTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
3 offices
active in Legal Services
operating since 1974
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 232 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 04.12.2008 - Priority Date (US 20080119844P)
  • 04.01.2017 - Publication A1 (EP3112361)